CIMT - The Association for Cancer Immunotherapy
Welcome to Europe’s largest meeting focused on cancer immunotherapy research and development.
CIMT is a members-based information and education platform that facilitates the knowledge exchange between academic and industry scientists, physicians and regulatory authorities who research and develop cancer immunotherapies. CIMT was founded in 2002 by physicians and researchers from different fields of clinical and theoretical medicine as an independent non-profit organization. CIMT has its offices in Mainz, Germany, and is financed by donations, congress fees, industry sponsorship and by public and foundation grants.
Visit the CIMT website | www.cimt.eu & meeting.cimt.eu